Major Acquisition to Advance Therapies for Treatment-Resistant Depression
Lilly will acquire AtaiBeckley in a deal valued at up to $3.8…
Lilly, Abu Dhabi Department of Health partner to advance AI-Powered Obesity and Alzheimer’s Care
Lilly and the Department of Health – Abu Dhabi have partnered to…
FDA approves Lilly’s EBGLYSS® for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis
The U.S. FDA has approved a new maintenance dosing regimen for Eli…
Lilly names Roberta Marinelli as new President & GM for Middle East & Türkiye.
Lilly has appointed Roberta Marinelli as the President and General Manager for…
Lilly Statement on FDA Advisory Committee Meeting on Donanemab
May 2024- The U.S. Food and Drug Administration (FDA) will convene an…
